Azam H, Shahrestani S, Phan K
If symptoms are severe, rapidly worsening, or concerning, call 911 or seek urgent medical care
This genetic insight may help your PlexusDx clinical team tailor your escalation pace and compound selection, though your monthly cost remains flat regardless of findings
Phase 1a studies in healthy volunteers, published in Diabetes, Obesity and Metabolism in 2023, established the compound's single-dose and multiple-dose pharmacokinetics, confirming a half-life supportive of once-daily dosing, a favorable food-effect profile, and dose-proportional exposure across the tested range
Traditionally, the Beighton score has been used as a quick clinical indicator of joint hypermobility but appropriate sex and age specific cut-offs should be used